Technology | January 31, 2013

Bionix Radiation Therapy introduces Accu-Tatt Tattooing System

Bionix Radiation Therapy Acu-Tatt Patient Positioning

January 31, 2013 — Accu-Tatt is an easy-to-use, sterile, all inclusive tattooing device designed to permanently mark radiation therapy patients. Every Accu-Tatt pouch conveniently contains an ink ampoule and a ¾-inch, 22-gauge needle. Packaging the needle and ampoule in a sterilized pouch reduces the concern for contamination and cross-contamination within radiation therapy facilities. In addition, Accu-Tatt’s short needle length allows for increased control while tattooing the patient. The Accu-Tatt shell contains an ampoule filled with sterile black ink. To start the flow of ink, hold the ampoule upright in one hand and use the thumb to bend the shell, breaking the ampoule. The end of the ampoule houses a luer lock fitting to accommodate the prepackaged, sterilized hypodermic needle.

Twenty-five individually wrapped Accu-Tatt systems will be packaged together in a dispensing box. Each pouch, containing the needle and ampoule, is sterilized.

Permanent tattoos are used during radiation therapy to mark the edge of the treatment field. These permanent markings help ensure the reproducibility of the patient throughout the treatment cycle.

The product is available now for immediate purchase.

For more information: www.bionixrt.com

Related Content

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri